You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》潤邁德醫療-B(02297.HK)料今年度或錄經調整後收支平衡
內地血管介入手術機器人公司潤邁德-B(02297.HK)今日(27日)起招股,執行董事、首席財務官兼聯席公司秘書張亮表示,根據公司目前盈利預測,預計經調整後今年度或將錄得收支平衡。 董事會主席、執行董事兼首席執行官霍雲飛表示,潤邁德醫療目標打造覆蓋綜合診療全流程、多產品的手術機械人平台,預期未來旗下血管介入機器人將會覆蓋冠狀動脈、腦血管、腎血管、肺血管、外周血管等領域。他又指,目前產品已分銷至捷克、法國及奧地利等地,並已與華潤醫藥(03320.HK)、漢喜醫療、平安資本及九州通醫療等訂立戰略框架協議,預期與分銷商的合作將可促進產品銷售,未來計劃加快拓展海外市場。 談及產品被納入醫保或影響售價,他認為,旗下產品有上市前已進行充分市場分析,普遍具有充分的價格調整空間,以應對未來當局帶量採購及納入醫保的情況。張亮補充,若產品最終納入醫保,預期即使降價,但整體銷售對營業收入都仍有正面影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account